Schedule 13G ownership disclosure

Celator Pharmaceuticals Inc

Security class unavailable · CUSIP: 15089R102

Event date: 2016-03-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-16-001290
Form type
SC 13G
Filer
Celator Pharmaceuticals Inc
CIK
CIK 1327467
Filed
Mar 15, 2016
Reporting period
Mar 14, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub